Nurse Anesthetist - CR in Winnsboro, TX Accepting Medicare

4 Nurse Anesthetist - CR nurses found. Showing 1 - 4

Mr. Juan Francisco Quintana, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 719 W Coke Rd, Presbyterian Hospital Winnsboro, Winnsboro, TX 75494 Phone: 903-342-5227    Fax: 903-342-4121

Mr. Eddie L Fontenot, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 719 W Coke Rd, Winnsboro, TX 75494 Phone: 903-707-4768

Mr. Michael Wayne Phillips, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 719 W Coke Rd, Presbyterian Hospital Winnsboro, Winnsboro, TX 75494 Phone: 903-342-5227    Fax: 903-342-4121

Mr. Theodore Knox Gregory Ii, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 719 W Coke Road, Presbyterian Hospital Winnsboro, Winnsboro, TX 75494 Phone: 903-342-5227    Fax: 903-342-4121

News Archive

Oregon, Minnesota exchanges weigh next steps

Officials overseeing the troubled exchanges examine what went wrong this year and debate how to proceed. Meanwhile, a small business exchange in Georgia gets few enrollees and The Denver Post reports that more residents signed up for Medicaid than for private insurance.

New research uncovers antibiotic prescription trends across England

New research by Antibiotic Research UK, the world's first charity created to develop new antibiotics in the fight against superbugs, and high-performance analytic database company EXASOL has discovered that while the number of antibiotic prescriptions is coming down across England, GP practices in the most deprived parts of the country are prescribing 20% more and, worryingly, antibiotic prescriptions are on the increase in these deprived areas.

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Friday, October 29, 2010 it submitted a complete response to the "Complete Response" letter issued by the U.S. Food and Drug Administration (FDA), regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.

Discovery of compound that reduces hallmark lesions of Alzheimer's disease in mice

Researchers at UC Irvine have found that a new compound not only relieves the cognitive symptoms of Alzheimer's disease, but also reduces the two types of brain lesions that are hallmarks of this devastating disease, thereby blocking its progression.

Apple, Bose and others pump up the volume on hearing aid options, filling void left by FDA

Spurred by decades of complaints about the high cost of hearing aids, Congress passed a law in 2017 to allow over-the-counter sales, with hopes it would boost competition and lower prices.

Read more Medical News

› Verified 3 days ago